Fujifilm Diosynth Biotechnologies combines novel technologies with over 25 years of biopharmaceutical contract manufacturing experience to bring you the best in process development and cGMP manufacturing. Whatever stage your product is at we have something to offer.
Fujifilm Diosynth Biotechnologies was formed in April 2011, following the acquisition of the former Diosynth Biotechnologies in Research Triangle Park, NC, USA, and the former Avecia Biologics in Billingham, UK, from Merck & Co Inc. As such the company has a long track record in the development and manufacture of biopharmaceuticals.
At Fujifilm Diosynth Biotechnologies we understand that each program is unique and often requires a different mix of our services. With each program managed by a dedicated program manager, we have devised a process to make sure that we always focus on your precise needs.